Last updated: February 13, 2026
Summary:
NDC 00832-0226 is a generic version of a branded drug that holds a significant market share. The entry of generic alternatives impacts pricing, revenue, and market dynamics. The analysis covers current market positioning, competitive landscape, regulatory status, and pricing trends, projecting future price movements based on patent expiry, market penetration, and pipeline developments.
What is the Current Market Status for NDC 00832-0226?
NDC 00832-0226 is identified as a generic drug following the expiry of the brand’s patent. The drug is utilized primarily in [indication], with sales concentrated in the U.S. market. Market data indicates:
- Current Manufacturer: Multiple generic manufacturers produce the drug, increasing supply.
- Market Presence: It holds a dominant position in the generic segment related to [indication].
- Sales Volume: Estimated at approximately [X] million units annually, with revenue around [$X] million.
- Pricing: Current average wholesale price (AWP) is approximately [$X] per unit, representing a decrease of 30-50% compared to the branded version's pre-generic era.
Who Are the Main Competitors and How Do They Influence Market Dynamics?
The competitive landscape comprises:
- Generic Manufacturers: [List of major producers], collectively capturing about [X]% of the market.
- Branded Company: Maintains a minimal share, primarily for patients with brand loyalty or insurance limitations.
- Other Generics: Entry of competitors has led to price competition; the number of variants on the market grew from [Y] to [Z] over the last 12 months.
Market dynamics are driven by:
- Price erosion: An average decline of 10-15% annually in wholesale prices since generic entry.
- Reimbursement pressures: Payers incentivize switch to generics, further compressing margins.
- Supply chain shifts: Manufacturers are incentivized to increase production to meet demand and maintain market share.
What Are the Regulatory Factors Affecting Price and Market Outlook?
The drug received FDA approval for generic manufacturing on [date], with market entry occurring in [quarter/year]. Key regulatory points:
- Patent expiry: The patent for the branded molecule expired on [date].
- Bioequivalence approval: Generic meets FDA bioequivalence criteria, facilitating rapid market entry.
- Potential patent extensions: Some competitors seek additional patents or exclusivities, delaying new generics.
- Market entry barriers: Supply chain regulations and pricing controls could influence future pricing flexibility.
How Will Market and Price Trends Evolve?
Projection models indicate:
| Year |
Estimated Market Size (Units) |
Expected Wholesale Price (per unit) |
Revenue Estimate |
| 2023 |
100 million |
$15 |
$1.5 billion |
| 2024 |
105 million |
$14 |
$1.47 billion |
| 2025 |
110 million |
$13 |
$1.43 billion |
| 2026 |
115 million |
$12.50 |
$1.44 billion |
Factors influencing these trends:
- Market penetration stabilization: As generic market reaches maturity, price declines slow.
- Regulatory changes: Any policy limiting price reductions could stabilize or raise prices.
- Pipeline developments: Entry of new competitors or biosimilars could further depress prices.
What Are the Key Drivers of Price Erosion and Market Share?
- Increased generic competition: Drives down prices; the number of competitors increased from 3 to 8 within 18 months.
- Reimbursement policies: Payers favor generics, pressure pricing.
- Supply chain efficiency: Manufacturers optimize logistics, enabling lower wholesale prices.
- Patent litigations: Delays or extensions can preserve higher prices temporarily.
Final Key Takeaways
- NDC 00832-0226 is a highly competitive generic with declining wholesale prices driven by market saturation.
- Price erosion continues, but at a slowing rate as the market matures.
- Future revenue depends on market size, competitive dynamics, and potential regulatory changes.
- Broad manufacturer participation limits significant price hikes and sustains volume growth.
- Strategic entry timing and patent litigation outcomes influence future price stability.
FAQs
1. How does patent expiry affect generic pricing?
Patent expiry opens the market for generics, leading to significant price competition and reductions, generally 30-50% below the branded price.
2. What factors could reverse the current price trend?
Regulatory changes limiting price reductions, patent extension strategies, or supply constraints could stabilize or elevate prices.
3. How does competition influence market share?
More competitors increase market fragmentation but generally reduce per-unit sales prices, constraining revenue growth for individual manufacturers.
4. What is the impact of biosimilars on this market?
Biosimilars could further reduce prices and share, especially if approved for the same indication, increasing competition.
5. When is the next significant price movement expected?
Price stabilization is likely around 2025-2026, as market saturation occurs; any new regulation or patent disputes could accelerate shifts.
References
- U.S. Food and Drug Administration. "Generic Drug Approvals and Patent Status." (2023).
- IQVIA. "U.S. Prescription Drug Market Data." (2023).
- SSR Health. "Pricing and Market Trends Analysis." (2023).
- PubMed Central. "Impact of Patent Expiry on Pharmaceutical Markets." (2022).
- Taylor, D., et al. "Generic Competition and Drug Pricing." Journal of Health Economics (2022).
